Difference between revisions of "Lnc-OR10H5-1:1"

From LncRNAWiki
Jump to: navigation, search
(Created page with "Please input one-sentence summary here. ==Annotated Information== ===Transcriptomic Nomeclature=== Please input transcriptomic nomeclature information here. ===Functio...")
 
Line 43: Line 43:
 
}}
 
}}
 
[[Category:Intergenic]]
 
[[Category:Intergenic]]
 +
 +
{{lncrnadb|
 +
tID = lnc-OR10H5-1:1|
 +
ltID = UCA1|
 +
ann = <tab class=wikitable sep=tab head=top>
 +
Section Description
 +
ID UCA1
 +
Characteristics Spliced and polyadenylated with 3 exons [http://www.ncbi.nlm.nih.gov/pubmed/18501714 (Wang (2008))]. Multiple isoforms (1.4kb, 2.2kb and 2.7kb). The 2.2kb isoform contains an extended final exon compared to the 1.4kb isoform while the 2.7kb isoform has not been characterised ([http://www.ncbi.nlm.nih.gov/pubmed/16914571 Wang (2006)], [http://www.ncbi.nlm.nih.gov/pubmed/17416635 Tsang (2007)], [http://www.ncbi.nlm.nih.gov/pubmed/18501714 Wang (2008)]). Sequence is mainly repeat elements. Initiates in an LTR, exons sample pieces of a HERV-H element and longer 2.2kb isoform contains a second LTR at the 3' end [http://www.ncbi.nlm.nih.gov/pubmed/16914571 (Wang (2006))].
 +
Expression Widely expressed in embryonic development [http://www.ncbi.nlm.nih.gov/pubmed/18501714 (Wang (2008))] and placenta [http://www.ncbi.nlm.nih.gov/pubmed/16914571 (Wang (2006))]. Low or no expression in normal adult tissue but highly upregulated in cell lines resistant to drug induced apoptotic cell death and bladder, colon and lung cancer ([http://www.ncbi.nlm.nih.gov/pubmed/16914571 Wang (2006)], [http://www.ncbi.nlm.nih.gov/pubmed/17416635 Tsang (2007)]). Identified as a biomarker for bladder cancer [http://www.ncbi.nlm.nih.gov/pubmed/16914571 (Wang (2006))].
 +
Function Functions of 1.4kb and 2.2kb isoforms have been investigated, both appear to promote and enhance tumourigenesis ([http://www.ncbi.nlm.nih.gov/pubmed/17416635 Tsang (2007)], [http://www.ncbi.nlm.nih.gov/pubmed/18501714 Wang (2008)]). Over-expression of 1.4kb isoform enhanced tumorigenic behavior of bladder cancer cells in-vitro and in-vivo. Increased drug resistance and cell motility [http://www.ncbi.nlm.nih.gov/pubmed/18501714 (Wang (2008))]. Overexpression of 2.2kb isoform caused resistance to drug induced apoptosis, potentially by downregulation of caspase 3 levels [http://www.ncbi.nlm.nih.gov/pubmed/17416635 (Tsang (2007))]. 2.2kb isoform promoted transformation in-vitro, possibly because resistance to apoptosis is an important step in tumourigenesis [http://www.ncbi.nlm.nih.gov/pubmed/17416635 (Tsang (2007))].
 +
Conservation Found in humans. May be present in other primates but not in more distantly related mammals [http://www.ncbi.nlm.nih.gov/pubmed/18501714 (Wang (2008))].
 +
Name Cancer up-regulated drug resistant (CUDR). Urothelial cancer associated 1 (UCA1)
 +
</tab>|
 +
}}

Revision as of 12:11, 6 October 2014

Please input one-sentence summary here.

Annotated Information

Transcriptomic Nomeclature

Please input transcriptomic nomeclature information here.

Function

Please input function information here.

Regulation

Please input regulation information here.

Expression

Please input expression information here.

Allelic Information and Variation

Please input allelic information and variation information here.

Evolution

Please input evolution information here.

You can also add sub-section(s) at will.

Labs working on this lncRNA

Please input related labs here.

References

Please input cited references here.

Basic Information

Transcript ID

lnc-OR10H5-1:1

Source

LNCipedia2.1

Same with

,

Classification

intergenic

Length

1441 nt

Genomic location

chr19+:15939770..15947051

Exon number

,

Exons

,

Genome context

Sequence
000001 TGACATTCTT CTGGACAATG AGTCCCATCA TCTCTCCACC ATGCACCTTG TGACTCCCTC CTCTGCTGAC AACAGATAAC 000080
000081 CACCTTTAAC TGTAACTTTC CACAGCCTAC CCCAGCCCTA TAAAGCTGCC CCTCTCCTAT CTCCCTTCGC TGACTCTCTT 000160
000161 TTCAGACTCA GCCCACTTGC ACCCAAGTGA ATTAACAGCC TTGTTGCTCA CACAAAGCCT GTTTAGGTGG TCTTCTATAC 000240
000241 GGACATGCTT GACACTTGGT GCCAAAATCT GGGCCAGGGG GACTCCTTCG TGAGACCGGC CCCCTGTCCT GGCCCTCATT 000320
000321 CCGTGAAGAG ATCCACCTGC GACCTCGGGT CCTCAGACCA GCCCAAGGAA CATCTCACCA ATTTCAAATC GGATCTCCTC 000400
000401 GGCTTAGTGG CTGAAGACTG ATGCTGCCCG ATCGCCTCAG AAGCCCCTTG GACCATCACA GATGCCGAGC TTCGGGTAAC 000480
000481 TCTTACGGTG GAGGATTCCC AGCCATATGA AGACACCCTA GCTGGACGAT CAGTCCTTGT CAAAAGTCTG ACCCCTCAAA 000560
000561 CTCTACAGCC TCAATGGACC AGACCCTACC CGGTCATTTA TAGCACACCA ACTGCCGTCC ATCTGCAGGA CCCTCTCCAT 000640
000641 TGGGTTCACC ATTCCAGAAT AAAGCCATGC CCATCAGACA GCCAGCTTGA TCTCTCCTCT TCCTCCTGGA AGCCACAAGA 000720
000721 TTAGGCCGAG AGCCGATCAG ACAAACAACC TACAACCCTT AAGCTCCTGG CAGCGCCCAG CCAAGGCCAT GCTTCCATGC 000800
000801 AACACTCCTT CCAAATGGCC ATCCCAGCAT GCTTCCAAGC AGGCTTCATC CGTTCCTCTG GACCCTCATC TCTTAAGACC 000880
000881 TGCCGCCTAT AAAAAGGATT ATATCTTGAG ACCCTATCCT CTAAAATTTT TTCCACACCC AAAACAAAAA ATCTCTGGGT 000960
000961 CAAAAGTCTA AAACGCTTAG GCTGGCAACC ATCAGATCCT TGCCCATGGT GTCCTCAAGC CTACTCTCAT GAAATGGACA 001040
001041 ACAGTACACG CATATGGGGC CAGTTCCACA TATTTGGCAA CCAGACCAGC ATCCAGGACA ACACAAAGTA TGTTGTTTGT 001120
001121 TGTTAGAGGG CTTGGGACAT TTCACTCTTT GCCAGCCTCA GCTTAATCCA GGAGACAAAG ATTATTTTCC TTATTATCTC 001200
001201 TTCTGCATAG GATCTGCAAT CAGAACTATT GAACTTCTCC ATTCAGACCG CCACTCACAC CTATGGGAAA AGGGTAATGT 001280
001281 ATCATCGGCT TAGCAACAGG GAATACTATT CGTATGATGG AAAATGGGGA CAAAAGGCTT TGGTACATAA AACATTATTC 001360
001361 CTTCCTTGGC CTAAAAACTC ATCGCCACCT ACATTAAAGC TAATATGCCT GATAAAAAAA AAAAAAAAAA AAAAAAAAAA 001440
001441 A
[back to top]


Annotation (From lncRNAdb)

[lnc-OR10H5-1:1]
Section Description
ID UCA1
Characteristics Spliced and polyadenylated with 3 exons (Wang (2008)). Multiple isoforms (1.4kb, 2.2kb and 2.7kb). The 2.2kb isoform contains an extended final exon compared to the 1.4kb isoform while the 2.7kb isoform has not been characterised (Wang (2006), Tsang (2007), Wang (2008)). Sequence is mainly repeat elements. Initiates in an LTR, exons sample pieces of a HERV-H element and longer 2.2kb isoform contains a second LTR at the 3' end (Wang (2006)).
Expression Widely expressed in embryonic development (Wang (2008)) and placenta (Wang (2006)). Low or no expression in normal adult tissue but highly upregulated in cell lines resistant to drug induced apoptotic cell death and bladder, colon and lung cancer (Wang (2006), Tsang (2007)). Identified as a biomarker for bladder cancer (Wang (2006)).
Function Functions of 1.4kb and 2.2kb isoforms have been investigated, both appear to promote and enhance tumourigenesis (Tsang (2007), Wang (2008)). Over-expression of 1.4kb isoform enhanced tumorigenic behavior of bladder cancer cells in-vitro and in-vivo. Increased drug resistance and cell motility (Wang (2008)). Overexpression of 2.2kb isoform caused resistance to drug induced apoptosis, potentially by downregulation of caspase 3 levels (Tsang (2007)). 2.2kb isoform promoted transformation in-vitro, possibly because resistance to apoptosis is an important step in tumourigenesis (Tsang (2007)).
Conservation Found in humans. May be present in other primates but not in more distantly related mammals (Wang (2008)).
Name Cancer up-regulated drug resistant (CUDR). Urothelial cancer associated 1 (UCA1)

[back to top]